Study yields positive results for breast cancer imaging agent

03/17/2013 | Yahoo

NuView Life Sciences' PET imaging agent for breast cancer, NLS-VPAC1, was able to detect 100% of malignant lesions and sentinel lymph nodes, according to findings presented at an international conference. Because of the agent's rapid uptake in tumors, the company is also investigating its use when labeled with the isotope gallium-68, which can be manufactured at local radiopharmacies. The agent may allow for noninvasive diagnosis of malignancies in the breast and other tissues, a researcher said.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ